Policy paper

PIP breast implants and regulation of cosmetic interventions

Government response to the House of Commons Health Committee

This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government


PIP Breast Implants and Regulation of Cosmetic Interventions: Command Paper

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk . Please tell us what format you need. It will help us if you say what assistive technology you use.


Government response to the House of Commons Health Committee report on problems resulting from the fraudulent use of non-medical grade silicone in the breast implants manufactured by the French company Poly Implant Prothèse (PIP) and the wider implications for the regulation of cosmetic interventions.

Published 14 May 2012